Both contain identical tirzepatide molecules but carry different FDA-approved indications which matters significantly for insurance coverage
Tirzepatide the dual GLP-1 plus GIP drug versus dulaglutide, which is pure GLP-1
Although there were no statistically significant differences between the treatment groups for adverse events, numbers of subjects reporting adverse events, serious adverse events, treatment-related adverse events, and severe adverse events were all greater in the treatment group (Table 12)
Beyond genetics, PlexusDx evaluates your metabolic phenotype through a comprehensive intake questionnaire covering appetite patterns, energy levels, food cravings, and previous medication responses
While Semaglutide and Tirzepatide are both GLP-1 agonists, they work in slightly different ways to support weight loss: Semaglutide targets GLP-1 receptors, helping to regulate appetite and improve blood sugar control
$16.00 B15 Injectable 250mg 30cc This B15 formula differs in chemical salts